BWX Technologies
Builds naval reactors and fuel alongside commercial nuclear equipment, services and medical isotopes.
Something off on this page? Send us feedback.
Profile
Builds naval nuclear reactors, components and fuel through Government Operations, while Commercial Operations supplies reactor equipment, lifecycle services and medical isotopes. Most activity is anchored in U.S. government programs, with a substantial Canadian commercial-nuclear base and a smaller international footprint.
Builds precision naval nuclear components, reactors and fuel for the U.S. government, while Government Operations also processes special nuclear materials and supports high-consequence federal sites. Operations are concentrated in the United States, with a substantial Canadian commercial-nuclear base and a smaller international footprint.
Commercial Operations supplies commercial-reactor components and lifecycle services, CANDU fuel and refurbishment capabilities, medical isotopes and radiopharmaceuticals. Acquisitions have added isotope infrastructure, plant-life services, specialty-material fabrication and U.S. heavy manufacturing.
Execution depends on regulated nuclear safety systems, controlled materials handling and exacting manufacturing. The business is shaped by U.S. government contracts, nuclear licensing and program funding; its mPower reactor development was wound down after funding proved insufficient. The current nuclear-focused identity dates to the 2015 separation of the power-generation business.
Company facts
Key statistics
Year to date −15.9% · Average volume (30d) 978.7K
Analysts
Ratings
Target range
Latest analyst notes
| Date | Firm | Action | Prior rating | Rating | Prior target | Target |
|---|---|---|---|---|---|---|
| Aug 27, 2026 | Wells Fargo | Upgrade | Underperform | $170 | ||
| Aug 14, 2026 | Truist Financial | Target | $205 | $202 | ||
| Jun 22, 2026 | Seaport Global | Upgrade | Neutral | Buy | $195 | $245 |
| Jun 18, 2026 | Seaport Global | Upgrade | Neutral | Buy | ||
| May 15, 2026 | Deutsche Bank | Upgrade | Hold | Buy | $205 | $255 |
Earnings
EPS
Revenue
History
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Next session |
|---|---|---|---|---|---|---|---|
| Aug 3, 2026Q2 FY26 | $1.04 | $1.07 | +2.9% | $902.4M | $901.6M | −0.1% | −0.80% |
| May 4, 2026Q1 FY26 | $0.92 | $1.12 | +21.7% | $837.5M | $860.2M | +2.7% | −4.87% |
| Feb 23, 2026Q4 FY25 | $0.89 | $1.08 | +21.2% | $837.5M | $885.8M | +5.8% | +2.95% |
| Nov 3, 2025Q3 FY25 | $0.85 | $1.00 | +17.2% | $793.4M | $866.3M | +9.2% | −7.17% |
Financial highlights
| 12 quarters | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | |
|---|---|---|---|---|---|---|---|
| Revenue | $682.3M | $764.0M | $866.3M | $885.8M | $861.1M | $901.6M | |
| Gross profit | $165.2M | $191.4M | $189.0M | $185.9M | $198.0M | $202.3M | |
| Operating income | $96.6M | $102.4M | $92.1M | $71.5M | $85.9M | $89.9M | |
| Net income | $75.5M | $78.4M | $82.1M | $93.0M | $91.2M | $89.0M | |
| Diluted EPS | $0.82 | $0.85 | $0.90 | $1.02 | $0.99 | $0.97 | |
| Gross margin | 24.2% | 25.1% | 21.8% | 21.0% | 23.0% | 22.4% | |
| Operating margin | 14.2% | 13.4% | 10.6% | 8.1% | 10.0% | 10.0% |
Fiscal years (4-quarter sums)FY21 $2.12B · FY22 $2.23B · FY23 $2.50B · FY24 $2.70B · FY25 $3.20B
Revenue by product · Q1 FY26
Revenue by geography · Q1 FY26
Balance sheet, Jun 30, 2026Cash & short-term investments $608.2M · Total debt $2.02B · Total assets $4.42B · Shareholders' equity $1.33B
Dividends
Raised for 10 straight years — most recently to $0.27 from $0.25 in Mar 2026. To collect a payout, hold shares through the close before the ex-date.
History
| Ex-date | Record | Paid | Amount | Note |
|---|---|---|---|---|
| Aug 18, 2026 | Aug 18 | Sep 4 | $0.27 | |
| May 19, 2026 | May 19 | Jun 5 | $0.27 | |
| Mar 11, 2026 | Mar 11 | Mar 27 | $0.27 | raised from $0.25 |
| Nov 19, 2025 | Nov 19 | Dec 10 | $0.25 | |
| Aug 18, 2025 | Aug 18 | Sep 5 | $0.25 | |
| May 19, 2025 | May 19 | Jun 5 | $0.25 | |
| Mar 11, 2025 | Mar 11 | Mar 28 | $0.25 | raised from $0.24 |
| Nov 19, 2024 | Nov 19 | Dec 10 | $0.24 |
Ownership
A 13F quarter can total more than the shares outstanding — sub-advisers file the same block twice, and a filer's own share count can be a quarter stale. No split is drawn from it.
Shares outstanding 91.61M · Float 90.89M · 99.2% free float
Top shareholders13F · 13D/G · Form 4
| Holder | Shares | % outstanding | Form | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 12.12M | 13.23% | 13F | Aug 7, 2026 |
| Vanguard Portfolio Management LLC | 4.76M | 5.19% | 13F | Aug 13, 2026 |
| Vanguard Capital Management LLC | 4.14M | 4.52% | 13F | Aug 13, 2026 |
| State Street Corp | 3.80M | 4.15% | 13F | Aug 7, 2026 |
| JPMorgan Chase & Co | 2.65M | 2.90% | 13F | Aug 12, 2026 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Aug 12, 2026 | Rex D. Geveden | director, officer: President and CEO | −10,000 | $172.50 |
| May 11, 2026 | Michael Thomas Fitzgerald | officer: SVP & Chief Financial Officer | −2,417 | $209.25 |
| May 12, 2026 | Rex D. Geveden | director, officer: President and CEO | −10,000 | $204.81 |
| Mar 2, 2026 | Kevin James Gorman | officer: VP & Chief Accounting Officer | −1,344 | $214.71 |
| Feb 25, 2026 | Gerhard F. Burbach | director | −1,983 | $208.61 |
Peers
- Amentum
Government engineering, nuclear cleanup, and national-security services
- Fluor
Government nuclear operations, remediation, and technical services
- Cameco
Uranium conversion, CANDU fuel manufacturing, and reactor components
- Huntington Ingalls Industries
Nuclear shipbuilding, naval lifecycle support, and DOE site services
- Leidos
DOE site operations, nuclear-security support, and federal engineering
- Northrop Grumman
Strategic deterrence, defense electronics, and space mission systems
CompareAfter-hours close
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| BWX Technologies | $153.62 | +0.47% | $14.00B | 39.4 | 30.4 | 4.0 | +18.0% |
| Amentum | $20.40 | +0.29% | $4.96B | 24.5 | 8.0 | 0.4 | −2.0% |
| Fluor | $53.27 | −0.05% | $7.44B | — | 16.5 | 0.5 | +8.8% |
| Cameco | $99.97 | −0.04% | $43.56B | 170.0 | 70.9 | 17.4 | −11.0% |
| Huntington Ingalls Industries | $294.11 | −0.03% | $11.59B | 17.5 | 15.1 | 0.9 | +10.9% |
| Leidos | $141.00 | +0.31% | $17.69B | 13.1 | 11.6 | 1.0 | +7.2% |
| Northrop Grumman | $546.65 | +0.20% | $77.51B | 17.3 | 18.6 | 1.8 | +5.1% |
| Median | 17.5 | 15.8 | 0.9 | +6.1% |